Vitiligo

Lieferzeit: Lieferbar innerhalb 14 Tagen

235,39 

ISBN: 3642422748
ISBN 13: 9783642422744
Herausgeber: Mauro Picardo/Alain Taïeb
Verlag: Springer Verlag GmbH
Umfang: xvii, 483 S.
Erscheinungsdatum: 13.12.2014
Auflage: 1/2014
Produktform: Kartoniert
Einband: Kartoniert

First highly up-to-date book showing new therapies for vitiligoLavishly illustrated covering all aspectsOverview on the classification, pathogenesis, methods of diagnosis and treatment of vitiligoAll therapy recommendations based on new evidence-based guidelines.Includes case studies with illustrations before and after the treatment demonstrating treatment successDesigned for beginners in the field and expertsIncludes supplementary material: sn.pub/extras

Artikelnummer: 7806720 Kategorie:

Beschreibung

Vitiligo has been, until recently, a rather neglected area in dermatology and medicine. Patients complain about this situation, which has offered avenues to quacks, and has led to the near orphan status of the disease. The apparently, simple and poorly symptomatic presentation of the disease has been a strong disadvantage to its study, as compared to other common chronic skin disorders such as psoriasis and atopic dermatitis. Vitiligo is still considered by doctors as a non disease, a simple aesthetic problem. A good skin-based angle of attack is also lacking because generalized vi- ligo is clearly epitomizing the view of skin diseases as simple targets of a systemic unknown dysregulation (diathesis), re? ecting the Hippocratic doctrine. This view has mostly restricted vitiligo to the manifestation of an auto-immune diathesis in the past 30 years. Thus, skin events, which are easily detected using skin biospies in most other situations, have not been precisely recorded, with the argument that a clinical diagnosis was suf? cient for the management (or most commonly absence of mana- ment) of the patient. This book is an international effort to summarize the information gathered about this disorder at the clinical, pathophysiological and therapeutic levels. Its primary aim is to bridge current knowledge at the clinical and investigative level, to point to the many unsolved issues, and to delineate future priorities for research.

Herstellerkennzeichnung:


Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …